Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers 论文

2013Nature引用 320
DOI
Melanoma and MAPK PathwaysProtein Tyrosine PhosphatasesComputational Drug Discovery Methods
Computational Drug Discovery MethodsMelanoma and MAPK PathwaysProtein Tyrosine Phosphatases
相关技术:Computational Drug Discovery Methods
关系图谱

Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers · 相关事件

暂无数据